: Global clinical oncology research is experiencing a profound structural shift, evolving from a historical underrepresentation of minority groups in Western-centric trials to a new representational imbalance marked by an increasing reliance on Chinese patient populations due to the nation's accelerating drug research and development. This article dissects this changing dynamic and proposes a systematic framework for a next-generation global oncology research and development paradigm that is inherently more inclusive, generalizable, and efficient for all patients worldwide.
Integrating China's Oncology Innovations into the Global Landscape: A Strategic Blueprint for Precision, Partnership, and Purpose / Ni, X., Zhang, T., Necchi, A., Pal, S.K., Ye, D., Zhu, Y.. - In: CANCER DISCOVERY. - ISSN 2159-8290. - 16:4(2026). [10.1158/2159-8290.CD-25-2050]
Integrating China's Oncology Innovations into the Global Landscape: A Strategic Blueprint for Precision, Partnership, and Purpose
Necchi, Andrea;
2026-01-01
Abstract
: Global clinical oncology research is experiencing a profound structural shift, evolving from a historical underrepresentation of minority groups in Western-centric trials to a new representational imbalance marked by an increasing reliance on Chinese patient populations due to the nation's accelerating drug research and development. This article dissects this changing dynamic and proposes a systematic framework for a next-generation global oncology research and development paradigm that is inherently more inclusive, generalizable, and efficient for all patients worldwide.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
